Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS

Not Applicable

Completed

• Conditions: HIV Infections; Peripheral Nervous System Disease

• Registration Number: NCT00002083
• Lead Sponsor: Advanced Peptides

Brief Summary

To compare the effects of intranasal peptide T and placebo in the treatment of painful peripheral neuropathy associated with human immunodeficiency virus (HIV) infection.

Detailed Description

Not available

Study Timeline

• Status Verified: 1993-03
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (4)

Univ of Miami School of Medicine; 🇺🇸 Miami, Florida, United States

Columbia Presbyterian Med Ctr; 🇺🇸 New York, New York, United States

Saint Luke's - Roosevelt Hosp Ctr; 🇺🇸 New York, New York, United States

Mount Sinai Med Ctr / Klingenstein Clinical Ctr; 🇺🇸 New York, New York, United States